Q1 earnings
Also: Blood glucose monitoring could be coming to next-gen consumer smartwatches; new incubator looking for disruptive health tech startups.
While the company saw a 25% increase in revenue year-over-year it failed to meet earnings per share expectations.
"Remote monitoring is here to stay," CEO Zane Burke said during yesterday's earnings call.